← All indications
Vascular Calcification
Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels is associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
Subtype terms (1)
More specific conditions that are subtypes of Vascular Calcification in the MeSH hierarchy.
Drugs by status
Phase 4 trials (14)
Phase 3 trials (9)
Phase 2 trials (5)
Phase 1 trials (4)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (15)
- Amgen
- Genzyme
- Albany College of Pharmacy and Health Sciences
- Albany Medical College
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Monash University
- Onze Lieve Vrouw Hospital
- Saint-Joseph University
- Far Eastern Memorial Hospital
- University of Angers
- Instituto Nacional de la Nutrición Salvador Zubiran
- OLV Hospital, Aalst, Belgium
- University of Antwerp
- Catholic University of Salta
- Universidad Católica de Salta
Organization Involved with Phase 3 Indications (17)
- Pfizer
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Aging (NIA)
- United States Department of Agriculture
- Ain Shams University
- Ege University
- Queen's University, Belfast
- RWTH Aachen University
- Tufts University
- University of Copenhagen
- North Zealand Hospital
- Dialysis Unit Erkelenz, Germany
- KfH Dialysis Centre Aachen, Schurzelter Strasse
- Instituto de Medicina Integral Professor Fernando Figueira
- AZ Sint-Jan
- Arthritis Foundation
- Federal University of Sao Paulo
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)